Workstream Type: Informing Dialogue
-
The Drugs at the Heart of Our Pricing Crisis
Read More
-
Biosimilars: Market Changes do not equal policy success
Read More
-
Curbing Biologic Drug Spending with P-quad
Read More
-
Ethics of Clinical Trials to Evaluate Biosimilars
Read More
-
COVID-19 Reduced Average Life Expectancy of Americans by Five Days, Not One Year
Read More
-
Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical Students
Read More
-
Research on the current state of US drug pricing and its effects
Read More
-
Who Is Sowing Seeds of Confusion About The QALY?
Read More
-
Before Spending Billions, U.S. Hospitals Need to Study Remdesivir Further
Read More
-
COVID-19 Urgency for a Vaccine Demands Patience
Read More